These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24733130)

  • 1. FDA application of the USP salt policy.
    Kremzner ME; Lal R; Stodart B
    Am J Health Syst Pharm; 2014 May; 71(9):694-6. PubMed ID: 24733130
    [No Abstract]   [Full Text] [Related]  

  • 2. USP says thousands of drug names look or sound alike.
    Thompson CA
    Am J Health Syst Pharm; 2008 Mar; 65(5):386-8. PubMed ID: 18281728
    [No Abstract]   [Full Text] [Related]  

  • 3. USP finds different medication-error patterns in seniors.
    Thompson CA
    Am J Health Syst Pharm; 2004 Jan; 61(1):16. PubMed ID: 14725115
    [No Abstract]   [Full Text] [Related]  

  • 4. Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study.
    Lambert BL; Schroeder SR; Galanter WL
    BMJ Qual Saf; 2016 Apr; 25(4):213-7. PubMed ID: 26700541
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing medication errors with nimodipine by compounding proper dosage forms.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):364-8. PubMed ID: 24459780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication errors.
    Rheinstein PH; McGinnis TJ
    Am Fam Physician; 1992 Jun; 45(6):2720-2. PubMed ID: 1595519
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA works toward product naming, packaging guidance.
    Traynor K
    Am J Health Syst Pharm; 2010 Aug; 67(16):1308-10. PubMed ID: 20689116
    [No Abstract]   [Full Text] [Related]  

  • 8. USP institutes new mandates for potassium chloride for injection concentrate.
    Eng JL
    Oncol Nurs Forum; 1993; 20(1):11. PubMed ID: 8421641
    [No Abstract]   [Full Text] [Related]  

  • 9. Medication errors related to product names.
    Santell JP; Cousins DD
    Jt Comm J Qual Patient Saf; 2005 Nov; 31(11):649-54. PubMed ID: 16335066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP to cut back on salt in drug names.
    Thompson CA
    Am J Health Syst Pharm; 2013 Jan; 70(2):94. PubMed ID: 23292260
    [No Abstract]   [Full Text] [Related]  

  • 11. The establishment of the Drug Naming Committee to restrict look-alike medication names in Iran: A qualitative study.
    Abolhassani N; Akbari Sari A; Rashidian A; Rastegarpanah M
    Int J Risk Saf Med; 2017; 29(1-2):69-79. PubMed ID: 28885221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatologic look- or sound-alike medications.
    Gremillion L; Hogan DJ
    J Drugs Dermatol; 2004; 3(1):61-4. PubMed ID: 14964748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Standardization of drug names.
    Lewis JR
    JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA proposes new rules that would require barcoding and new reporting procedures.
    Healthc Leadersh Manag Rep; 2003 Mar; 11(3):12-3. PubMed ID: 12803025
    [No Abstract]   [Full Text] [Related]  

  • 15. Coverage of FDA medication boxed warnings in commonly used drug information resources.
    Cheng CM; Guglielmo BJ; Maselli J; Auerbach AD
    Arch Intern Med; 2010 May; 170(9):831-3. PubMed ID: 20458094
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA to develop rules for mandatory bar-code labels.
    Thompson CA
    Am J Health Syst Pharm; 2002 Jan; 59(2):107, 112. PubMed ID: 11826558
    [No Abstract]   [Full Text] [Related]  

  • 17. Rx package inserts: redesigned with fewer errors in mind.
    Fass JA; Seamon MJ; Cytacki J
    J Fam Pract; 2007 Jun; 56(6):438-41. PubMed ID: 17543253
    [No Abstract]   [Full Text] [Related]  

  • 18. CDC and FDA response to risk of confusion in dosing Tamiflu oral suspension.
    Budnitz DS; Lewis LL; Shehab N; Birnkrant D
    N Engl J Med; 2009 Nov; 361(19):1913-4. PubMed ID: 19797275
    [No Abstract]   [Full Text] [Related]  

  • 19. The political economy of FDA drug review: processing, politics, and lessons for policy.
    Carpenter DP
    Health Aff (Millwood); 2004; 23(1):52-63. PubMed ID: 15002628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication errors caused by confusion of drug names.
    Hoffman JM; Proulx SM
    Drug Saf; 2003; 26(7):445-52. PubMed ID: 12735783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.